Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01996605 · ClinicalTrials.gov registry record · Phase 2
Efficacy of Spinal Oxytocin in Healthy Volunteers
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT01996605 is a Phase 2 study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants.
The verdict
NCT01996605, a Phase 2 study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of intrathecal oxytocin on areas and intensity of hyperalgesia and allodynia induced by topical capsaicin.
Interventions
- DRUG Placebo
- DRUG Oxytocin 15 mcg
- DRUG Oxytocin 150 mcg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-01-02 |
| Est. Completion | 2022-10-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01996605
The ClinicalTrials.gov registry entry for NCT01996605 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01996605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01996605 about?
NCT01996605 is a clinical study titled "Efficacy of Spinal Oxytocin in Healthy Volunteers". The purpose of this study is to determine the effect of intrathecal oxytocin on areas and intensity of hyperalgesia and allodynia induced by topical capsaicin.
What is the current status of trial NCT01996605?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2014-01-02. Estimated completion is 2022-10-10.
What interventions are being tested in trial NCT01996605?
The interventions under investigation include: Placebo (DRUG), Oxytocin 15 mcg (DRUG), Oxytocin 150 mcg (DRUG).
Who is sponsoring clinical trial NCT01996605?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.